CN1579490A - Traditional Chinese medicinal preparation for women's menalgia - Google Patents

Traditional Chinese medicinal preparation for women's menalgia Download PDF

Info

Publication number
CN1579490A
CN1579490A CN 200410018563 CN200410018563A CN1579490A CN 1579490 A CN1579490 A CN 1579490A CN 200410018563 CN200410018563 CN 200410018563 CN 200410018563 A CN200410018563 A CN 200410018563A CN 1579490 A CN1579490 A CN 1579490A
Authority
CN
China
Prior art keywords
chinese medicine
treatment
medicine preparation
dysmenorrhes
glycerol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200410018563
Other languages
Chinese (zh)
Inventor
玄振玉
于莉
陈麟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200410018563 priority Critical patent/CN1579490A/en
Publication of CN1579490A publication Critical patent/CN1579490A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention belongs to medicine technology field, which concretely is a Chinese traditional medicine for curing women dysmenorrheal. The medicine includes nutagrass flatsedge rhizome, glycerin, isinglass and antiseptic and accessories. Its character lies in: the proportion of the prescription is: the nutagrass flatsedge rhizome volatile oil is 30-150mg, the isinglass is 10 shares, and the glycerin is 3-4 shares and proper amount of antiseptic agent. Compared with current technology, it extracts the acting part of the effective ingredients in the Chinese traditional medicine, upgrades the curative effect, and uses popular soft capsule preparation; the sufferer is easy to accept. The soft capsule has a quick action, high biology utilization rate compared with other solid preparations.

Description

A kind of Chinese medicine preparation for the treatment of dysmenorrhes
[technical field]
The invention belongs to medical technical field, specifically a kind of Chinese medicine preparation for the treatment of dysmenorrhes.
[technical background]
Dysmenorrhea (Dys menorrhea) is meant between moon paramenstrum, lower abdomen and waist spasmic pain, when serious with feel sick, vomiting, cold extremities, especially be more common in unmarried young women, dysmenorrhea can be divided into 2 big classes, a kind of is the obvious pathological changes of non-reproductive system, is called primary dysmenorrhea (Primary Dys menorrhea), generally begins and will take place in menophania.Another kind is the dysmenorrhea that is caused by clear and definite disease, secondary dysmenorrhea (Secondary Dys menorrhea), itself and primary dysmenorrhea have obvious difference, can cause that the time that dysmenorrhea occurs is just to begin after menorrhea a period of time (mostly being 3 years) to take place by genital organ diseases such as edeitis, hysteromyoma, endometriosis.Epidemiological study shows that primary dysmenorrhea is the common disease of present gynecological, uses different investigation methods, and its rate is between 20%~90%, for influencing the common cause of women's operate as normal and quality of life.
Dysmenorrhea is owing to its high incidence causes people's attention, in several investigation, find at young women, woman worker's absence rate that dysmenorrhea causes is between 34%~50%, about 10% primary dysmenorrhea patient can seriously have to work in 1~3 day to every month, the absence rate that causes in this situation of the U.S. and when thinking that corresponding economic loss has 600,000,000 work about every year and 2,000,000,000 dollars.In addition, be in a bad way but still adhere in the middle of the patient of work that cause productivity ratio to descend easily, possibility of accident occurrence rises, degradation under the work quality at those.The appearance of NSAID (non-steroidal anti-inflammatory drug) and oral contraceptive makes this sick sickness rate greatly reduce.In recent years, pathogenesis and the treatment to primary dysmenorrhea both at home and abroad had further research, and obtained many achievements.Motherland's medical science also has extraordinary effect for dysmenorrhea treatment, and efficacy consolidation, toxic and side effects are little, and unique advantage is arranged.But it is still less and not deep for the research of this respect both at home and abroad.For the research of the mechanism of Chinese medicine dysmenorrhea, and, become a big problem of Chinese medicine research worker how to its exploitation and apply to clinically.
Chinese medicine is to TREATMENT OF DYSMENORRHOEA, and curative effect is by clinical confirmation.The traditional Chinese medical science thinks that primary dysmenorrhea mainly is because the women between menstrual period, is subjected to the influence of paathogenic factor, cause dashing and appoint strongly fragrant resistance or cold accumulating in meridian, make QI-blood circulation not smooth, the circulation of uterus menses is obstructed, consequently " stagnation of QI and blood may bring about pain " or dash to appoint, uterus lose in moistening foster, Rong Ze pain.Time, character according to pain, and menstruation characteristics, patient's body constitution etc. is carried out determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs when passing through, dysmenorrhea can be divided into pattern of syndrome such as qi depression to blood stasis, cold and stagnate, dampness and heat stasis, deficient qi and blood, deficiency of both the liver and kidney, utilization classic prescriptions such as SHAOFU ZHUYN DECOCTION, SIWU TANG, decoction for warming channels, accent liver soup etc. are added to simplify to carry treats, and can obtain better therapeutic effect.
Rhizoma Cyperi is the dry rhizome of sedge dried tuber Cyperusrotunduslinn, is conventional Chinese medicine, has the effect that bleed resolving depression, regulating menstruation alleviate pain.The Rhizoma Cyperi fluid extract can suppress the contraction of Cavia porcellus, rabbit, cat, dog plasmon palace (pregnant and unpregnancy), studies its effective ingredient at present and is mainly α-cyperone.Experiment showed, that the spontaneity that can suppress unpregnancy isolated rat uterus muscle effectively shrinks, suppress the contraction of the isolated uterine flesh that oxytocin causes simultaneously, and be dose-dependence, is the main effective ingredient that the Rhizoma Cyperi regulating menstruation is alleviated pain.
[summary of the invention]
The objective of the invention is basis the Chinese medicine preparation and the preparation technology thereof that dose is big, uncertain therapeutic efficacy is cut, the uppity shortcoming of quality provides a kind of and fills a prescription rationally, curative effect is fast, side effect is little of similar preparation in the past.
A kind of Chinese medicine preparation for the treatment of dysmenorrhes is provided for achieving the above object, comprise adjuvants compositions such as Chinese medicine Rhizoma Cyperi and gelatin, glycerol, antiseptic, it is characterized in that: the proportioning of prescription is Rhizoma Cyperi volatile oil 30-150mg, 10 parts in gelatin, glycerol 3-4 part and an amount of antiseptic; Dosage form can be soft capsule, drop pill and transdermal absorption formulation; Chinese medicine preparation soft capsule product comprises softgel shell and content composition, wherein contains 10 parts in gelatin, glycerol 3-4 part and an amount of antiseptic in every softgel shell, and the content in every capsules is every and contains Rhizoma Cyperi volatile oil 30-150mg and an amount of solvent and stabilizing agent; Purposes also can be used for making an addition on the carriers such as sanitary towel, cotton wool as adjuvant to be used.
Preparation technology of the present invention may further comprise the steps: get it filled (1): in Rhizoma Cyperi 1-5 part ratio; (2) pulverize; (3) extract: extract the volatile oil component through the method for supercritical fluid extraction or the method for vapor distillation; (4) mix: add proper amount of edible vegetable oil, glycerol and suitable quantity of water mix homogeneously; (5) pelleting: degassing back compacting; (6) drying; (7) get finished product.
The present invention compares with prior art, extracts the useful effect position of Chinese medicine, has improved therapeutic effect, and adopt popular soft capsule preparation, make the patient be easy to accept, and, soft capsule is other oral solid formulations relatively, have characteristics rapid-action, that bioavailability is high and advantage.
[description of drawings]
Fig. 1 is a process chart of the present invention.
Referring to accompanying drawing, 1 for getting it filled, and 2 for pulverizing, and 3 for extracting, and 4 for mixing, and 5 be pelleting, and 6 is drying, 7 be finished product.
[specific embodiment]
The invention will be further described below in conjunction with accompanying drawing.
Getting the Chinese medicine Rhizoma Cyperi earlier pulverizes, extract total volatile oil through the method for supercritical fluid extraction or the method for vapor distillation, it is miscible to add edible vegetable oil then, then add an amount of glycerol and suitable quantity of water mix homogeneously, through being pressed into ball after the degassing, carry out dried at last, get product, every contains Rhizoma Cyperi volatile oil 30-150mg.

Claims (5)

1. a Chinese medicine preparation for the treatment of dysmenorrhes comprises adjuvants compositions such as Chinese medicine Rhizoma Cyperi and gelatin, glycerol, antiseptic, it is characterized in that: the proportioning of prescription is Rhizoma Cyperi volatile oil 30-150mg, 10 parts in gelatin, glycerol 3-4 part and an amount of antiseptic.
2. as claims 1 described a kind of Chinese medicine preparation for the treatment of dysmenorrhes, it is characterized in that: dosage form can be soft capsule, drop pill and transdermal absorption formulation.
3. as claims 1 or 2 described a kind of Chinese medicine preparation for the treatment of dysmenorrhes, it is characterized in that: Chinese medicine preparation soft capsule product comprises softgel shell and content composition, wherein contain 10 parts in gelatin, glycerol 3-4 part and an amount of antiseptic in every softgel shell, the content in every capsules is Rhizoma Cyperi volatile oil 30-150mg and an amount of solvent and stabilizing agent.
4. as claims 1 described a kind of Chinese medicine preparation for the treatment of dysmenorrhes, it is characterized in that: purposes also can be used for making an addition on the carriers such as sanitary towel, cotton wool as adjuvant to be used.
5. as claims 1 described a kind of Chinese medicine preparation for the treatment of dysmenorrhes, it is characterized in that: preparation technology may further comprise the steps: get it filled (1): in Rhizoma Cyperi 1-5 part ratio; (2) pulverize; (3) extract: extract the volatile oil component through the method for supercritical fluid extraction or the method for vapor distillation; (4) mix: add proper amount of edible vegetable oil, glycerol and suitable quantity of water mix homogeneously; (5) pelleting: degassing back compacting; (6) drying; (7) get finished product.
CN 200410018563 2004-05-21 2004-05-21 Traditional Chinese medicinal preparation for women's menalgia Pending CN1579490A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410018563 CN1579490A (en) 2004-05-21 2004-05-21 Traditional Chinese medicinal preparation for women's menalgia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410018563 CN1579490A (en) 2004-05-21 2004-05-21 Traditional Chinese medicinal preparation for women's menalgia

Publications (1)

Publication Number Publication Date
CN1579490A true CN1579490A (en) 2005-02-16

Family

ID=34581844

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410018563 Pending CN1579490A (en) 2004-05-21 2004-05-21 Traditional Chinese medicinal preparation for women's menalgia

Country Status (1)

Country Link
CN (1) CN1579490A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101927031A (en) * 2010-09-03 2010-12-29 云南清逸堂实业有限公司 Sanitary towel heat sensitizer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101927031A (en) * 2010-09-03 2010-12-29 云南清逸堂实业有限公司 Sanitary towel heat sensitizer

Similar Documents

Publication Publication Date Title
CN102178804B (en) Chinese medicinal composition for treating perianal eczema and preparation method thereof
CN104958607A (en) Traditional Chinese medicine composition for treating burning mouth syndromes of climacteric women and preparation method thereof
CN102120020B (en) Medicinal composition for treating hyperplastic diseases of breast and hysteromyoma and preparation method thereof
CN103690782B (en) A kind of Chinese medicine composition, preparation method and quality determining method for the treatment of climacteric syndrome
CN104983916B (en) There are health product of enhancing immunity and slow down aging and preparation method and application
CN100450517C (en) Dysmenorrhea treating Chinese traditional medicine preparation
CN100443074C (en) Heat-clearing and stranguria-relieving Chinese medicine preparation and production thereof
CN101028325B (en) Medicinal composition containing sailonggu, and its preparation and quality detection method
CN103099844B (en) Traditional Chinese medicinal composition for treating infant eczema
CN1939427B (en) Prickly polygonum extract, its preparation, medicinal composition and use
CN101264314A (en) Medicaments assembly for clearing heat and detoxication, activating blood circulation and removing stasis, and diminishing inflammation and reducing pain
CN104523603A (en) Traditional Chinese medicine granules and preparation method and use thereof
CN101361950A (en) Gynaecologic traditional Chinese medicine capable of dispelling coldness, promoting blood and alleviating pain and preparation method thereof
CN1579490A (en) Traditional Chinese medicinal preparation for women's menalgia
CN103191399A (en) Traditional Chinese medicine composition for treating bronchial asthma in acute-outbreak period
CN103919961B (en) Middle and old age kidney-jing deficiency and kidney yang deficiency treatment traditional Chinese medicine preparation and preparation method thereof
CN102198251B (en) Chinese medicinal composition for treating climacteric syndrome and preparation method thereof
CN103041288B (en) A kind of Chinese medicine composition and preparation technology treating diabetic fatty liver
CN104173521B (en) A kind of pharmaceutical composition and its preparation method giving birth to able-bodied sun
CN102846679A (en) Composition with weight losing effect
CN102204871A (en) Composition for weight loss
CN102614380B (en) Traditional Chinese medicinal composition pulvis and tablets for treating primary osteoporosis, preparation method thereof and health-care product
CN105998290A (en) Traditional Chinese medicine composition for treating early woman amenorrhea and preparing method thereof
CN106620066A (en) Traditional Chinese medicine composition for promoting estrus and pregnancy of animals and preparation method thereof
CN104398987A (en) Chinese medicinal composition for treating cold accumulation-caused blood stasis type dysmenorrhea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication